Quasar Medical, a contract development and manufacturing organization (CDMO) specializing in minimally invasive medical devices, announced the acquisition of the Medres' Nitinol Design and Development Center in San Diego, California.
The acquisition expands Quasar's capabilities in Nitinol design, development and manufacturing, while strengthening its global technology organization under the leadership of Christine Trepanier, senior vice president of technology.
The transaction includes the 10,000-square-foot site in San Diego, established in 2024, with dedicated Nitinol operations, engineering talent, and manufacturing capabilities. Medres International will continue operating its remaining business independently, while Quasar assumes responsibility for the Nitinol business and its customers.
As demand continues to grow for increasingly sophisticated minimally invasive devices, Nitinol remains one of the industry's most important enabling technologies. By integrating the San Diego team into Quasar's global engineering and manufacturing network, customers will gain access to expanded technical expertise, accelerated product development, and a seamless path from concept through commercial manufacturing at Quasar's Tecate, Mexico facility, just a 1-hour drive from San Diego.
The San Diego facility will become Quasar Medical's Nitinol Design and Development Center, serving as a hub for advanced Nitinol design, development, process engineering, and manufacturing. Working alongside Quasar's global technology and manufacturing teams, the facility will support customers throughout every stage of the product lifecycle—from concept development and prototyping through process validation and high-volume production.
The acquisition enhances Quasar's ability to provide:
- Comprehensive Nitinol Expertise. Advanced design, development, prototyping, process optimization, and precision manufacturing capabilities, including laser cutting, shape setting, and electropolishing.
- Integrated Product Development. Early engineering collaboration combined with Quasar's expertise in catheters, balloons, steerable systems, microsensors, and complex assemblies.
- Accelerated Time to Market. Seamless transition from innovation and prototype development to global commercial manufacturing.
- Global Scale and Quality. Access to Quasar's worldwide manufacturing network, supported by ISO 13485-certified facilities and proven operational excellence.
